Original paperTauroursodeoxycholate prevents taurolithocholate-induced cholestasis and toxicity in rat liver
This paper is dedicated to Professor Dr. K.-H. Meyer zum Büschenfelde on the occasion of his 60th birthday.
References (27)
- et al.
Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?
Lancet
(1987) - et al.
Mechanism of cholic acid protection in lithocholate-induced intrahepatic cholestasis in rats
Gastroenterology
(1980) - et al.
Effect of ursodeoxycholik acid (UDCA) treatment in patients with hypertransaminasemia: a double-blind clinical trial
Gastroenterology
(1988) - et al.
Ursodeoxycholk acid (UDCA) reduces secondary liver damage in primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC)
Hepatology
(1988) - et al.
Tauroursodeoxycholate (TUDC) reduces ductular proliferation and portal inflammation in bile-duct-ligated hamsters
Hepatology
(1983) - et al.
Tauroursodeoxycholate prevents biliary protein excretion induced by other bile salts in the rat
Am J Physiol
(1985) - et al.
Effect of sodium taurolithocholate on bile flow and bile acid excretion
J Clin Invest
(1968) - et al.
Acute cholestasis induced by lithocholic acid in the rat
Lab Invest
(1975) - et al.
The respective roles of membrane cholesterol and of sodium potassium adenosine triphosphatase in the pathogenesis of lithocholate-induced cholestasis
Lab Invest
(1980) - et al.
Reduced cholestatic potency of taurolithocholate during backward perfusion of the rat liver
Lab Invest
(1987)
Subcellular pathology of rat liver in cholestasis and choleresis induced by bile salts. 1. Effects of lithocholic, 3β-hydroxy-5-cholenoic, cholic, and dehydrocholic acids
Lab Invest
(1977)
Protective effect of Ursodeoxycholk acid against cholestatic and hepatotoxic effects of lithocholic acid
Hepatology
(1982)
Structural and functional integrity of rat liver perfused in backward and forward directions
Res Exp Med
(1986)
Cited by (0)
Copyright © 1990 Published by Elsevier Ireland Ltd.